Physician profile
Pamela Dawn Branson
NPI 1679225130
$530.68
in general payments reported to CMS, 2019-2025
14 companies · $35.67 in 2025
The $35.67 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $287 · 2023: $194 · 2024: $14.23 · 2025: $35.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200 · Education: $43.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.00 |
| Education | $43.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $180.81 | 2022-2023 | Farxiga |
| Novo Nordisk INC | $80.85 | 2022 | |
| Amgen INC. | $47.98 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.78 | 2022-2025 | Jardiance |
| Calliditas Therapeutics US INC. | $24.80 | 2023 | Tarpeyo |
| Akebia Therapeutics INC | $23.78 | 2022 | |
| Sanofi-Aventis U.S. LLC | $23.73 | 2022 | |
| Amarin Pharma, INC. | $17.59 | 2022 | |
| Pfizer INC. | $17.21 | 2022 | |
| Ardelyx, INC. | $16.82 | 2025 | Ibsrela |
| Mylan Specialty L.P. | $16.51 | 2022 | |
| Medicomp INC | $15.85 | 2022 | |
| Fresenius USA Marketing, INC. | $14.23 | 2024 | Velphoro |
| Glaxosmithkline, LLC. | $11.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Branson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.